Antistoffer mod hirudin, hvilket sås hos flere af de behandlede aber, resulterede i en forlængelse af den terminale halveringstid og en øgning i den systemiske eksponering for lepirudin.
Antibodies against hirudin which appeared in several of the treated monkeys resulted in prolongation of the terminal half-life and an increase in systemic exposure to lepirudin.